These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 35438780

  • 1. Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review.
    Fitzpatrick A, Cooper C, Vasilunas N, Ritchie B.
    Clin Infect Dis; 2022 Oct 12; 75(8):1467-1480. PubMed ID: 35438780
    [Abstract] [Full Text] [Related]

  • 2. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy.
    Nigro G, Muselli M, On Behalf Of The Congenital Cytomegalic Disease Collaborating Group.
    Viruses; 2023 Jun 15; 15(6):. PubMed ID: 37376675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
    D'Antonio F, Marinceu D, Prasad S, Khalil A.
    Ultrasound Obstet Gynecol; 2023 Apr 15; 61(4):436-444. PubMed ID: 36484439
    [Abstract] [Full Text] [Related]

  • 6. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
    Nigro G.
    Expert Rev Anti Infect Ther; 2017 Nov 15; 15(11):977-986. PubMed ID: 29072089
    [Abstract] [Full Text] [Related]

  • 7. New evidence on prognostic features, prevention and treatment of congenital Cytomegalovirus infection.
    Sebghati M, Khalil A.
    Curr Opin Obstet Gynecol; 2020 Oct 15; 32(5):342-350. PubMed ID: 32739974
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO, Enders M, Schampera MS, Baeumel E, Hoopmann M, Geipel A, Berg C, Goelz R, De Catte L, Wallwiener D, Brucker S, Adler SP, Jahn G, Hamprecht K.
    Ultrasound Obstet Gynecol; 2019 Mar 15; 53(3):383-389. PubMed ID: 29947159
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V, Hackelöer M, Rancourt RC, Henrich W, Siedentopf JP.
    Arch Gynecol Obstet; 2020 Dec 15; 302(6):1353-1359. PubMed ID: 32754858
    [Abstract] [Full Text] [Related]

  • 14. Management of cytomegalovirus infection in pregnancy: is it time for valacyclovir?
    Zammarchi L, Lazzarotto T, Andreoni M, Campolmi I, Pasquini L, Di Tommaso M, Simonazzi G, Tomasoni LR, Castelli F, Galli L, Borchi B, Clerici P, Bartoloni A, Tavio M, Trotta M.
    Clin Microbiol Infect; 2020 Sep 15; 26(9):1151-1154. PubMed ID: 32289479
    [Abstract] [Full Text] [Related]

  • 15. Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study.
    Kagan KO, Enders M, Hoopmann M, Geipel A, Simonini C, Berg C, Gottschalk I, Faschingbauer F, Schneider MO, Ganzenmueller T, Hamprecht K.
    Ultrasound Obstet Gynecol; 2021 Apr 15; 57(4):560-567. PubMed ID: 33491819
    [Abstract] [Full Text] [Related]

  • 16. Findings and conclusions from CMV hyperimmune globulin treatment trials.
    Adler SP, Nigro G.
    J Clin Virol; 2009 Dec 15; 46 Suppl 4():S54-7. PubMed ID: 19781985
    [Abstract] [Full Text] [Related]

  • 17. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
    Buxmann H, Stackelberg OM, Schlößer RL, Enders G, Gonser M, Meyer-Wittkopf M, Hamprecht K, Enders M.
    J Perinat Med; 2012 Mar 27; 40(4):439-46. PubMed ID: 22752777
    [Abstract] [Full Text] [Related]

  • 18. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight.
    Nigro G, Capretti I, Manganello AM, Best AM, Adler SP.
    J Matern Fetal Neonatal Med; 2015 Jan 27; 28(2):168-71. PubMed ID: 24660895
    [Abstract] [Full Text] [Related]

  • 19. Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: A case-series.
    De Santis M, Apicella M, De Luca C, D'Oria L, Valentini P, Sanguinetti M, Lanzone A, Scambia G, Santangelo R, Masini L.
    J Clin Virol; 2020 Jun 27; 127():104351. PubMed ID: 32325395
    [Abstract] [Full Text] [Related]

  • 20. Secondary prevention of congenital cytomegalovirus infection with valacyclovir following maternal primary infection in early pregnancy.
    Faure-Bardon V, Fourgeaud J, Stirnemann J, Leruez-Ville M, Ville Y.
    Ultrasound Obstet Gynecol; 2021 Oct 27; 58(4):576-581. PubMed ID: 33998084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.